Cardiovascular disease is a common problem in cancer patients that is becoming more widely recognized. This may be a consequence of prior cardiovascular risk factors but could also be secondary to the anticancer treatments. With the goal of offering a multidisciplinary approach to guaranteeing optimal cancer therapy and the early detection of related cardiac diseases, and in light of the recent ESC Cardio-Oncology Guideline recommendations, we developed a Cardio-Oncology unit devoted to the prevention and management of these specific complications. This document brings together important aspects to consider for the development and organization of a Cardio-Oncology program through our own experience and the current evidence.
心血管疾病是癌症患者中日益受到广泛关注的常见问题。这可能是既往心血管危险因素所致，也可能是抗癌治疗的继发影响。基于欧洲心脏病学会肿瘤心脏病学指南的最新建议，我们成立了专门的肿瘤心脏病学单元，旨在通过多学科协作模式，确保癌症患者获得最佳治疗方案，并实现相关心脏疾病的早期检测，从而预防和管理这些特定并发症。本文结合我们自身的实践经验与现有循证证据，系统阐述了建立和运行肿瘤心脏病学项目需重点考量的关键要素。
肿瘤(癌症)患者之家